Levophacetoperane inhibits in vitro in a competitive manner, norepinephrin uptake and dopamine uptake. IC50 & Target: Norepinephrin uptake^[1]
Dopamine uptake^[1] In Vitro: Levophacetoperane inhibits in vitro in a competitive manner, norepinephrin uptake in Rat hypothalamus and cortex, and dopamine uptake in corpus striatum and cortex. Levophacetoperane is a psychostimulant^[1]. Levophacetoperane has been used as an antidepressant and anorectic. Levophacetoperane is the reverseester of methylphenidate.